{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:31:10Z","timestamp":1772119870703,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T00:00:00Z","timestamp":1714348800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T00:00:00Z","timestamp":1714348800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2022M3A9G1014476"],"award-info":[{"award-number":["2022M3A9G1014476"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2019R1C1C1010887"],"award-info":[{"award-number":["2019R1C1C1010887"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005006","name":"Asan Institute for Life Sciences, Asan Medical Center","doi-asserted-by":"publisher","award":["2021IL0030"],"award-info":[{"award-number":["2021IL0030"]}],"id":[{"id":"10.13039\/501100005006","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["HI21C1317"],"award-info":[{"award-number":["HI21C1317"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Reserch Foundation of Korea","award":["2022R1Z1A1A01066589"],"award-info":[{"award-number":["2022R1Z1A1A01066589"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Imaging Biol"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1007\/s11307-024-01918-w","type":"journal-article","created":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T15:01:40Z","timestamp":1714402900000},"page":"638-648","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Comparison of the Pharmacokinetics of Gadolinium-Based and Iron Oxide-Based Contrast Agents inside the Lymphatic Structure using Magnetic Resonance Lymphangiography"],"prefix":"10.1007","volume":"26","author":[{"given":"Yeon Ji","family":"Chae","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyung Won","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mi-hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chul-Woong","family":"Woo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang-Tae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji-wook","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tae-Hyun","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Do-Wan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeong Kon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoonseok","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8202-015X","authenticated-orcid":false,"given":"Dong-Cheol","family":"Woo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,4,29]]},"reference":[{"key":"1918_CR1","doi-asserted-by":"publisher","first-page":"2771","DOI":"10.1007\/s00330-009-1461-z","volume":"19","author":"M Notohamiprodjo","year":"2009","unstructured":"Notohamiprodjo M, Baumeister RGH, Jakobs TF et al (2009) MR-lymphangiography at 3.0T-a feasibility study. Eur Radiol 19:2771\u20132778","journal-title":"Eur Radiol"},{"key":"1918_CR2","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1148\/radiol.12110229","volume":"264","author":"M Notohamiprodjo","year":"2012","unstructured":"Notohamiprodjo M, Weiss M, Baumeister RG et al (2012) MR lymphangiography at 3.0 T: correlation with lymphoscintigraphy. Radiology 264:78\u201387","journal-title":"Radiology"},{"key":"1918_CR3","doi-asserted-by":"publisher","first-page":"E435","DOI":"10.1016\/j.crad.2014.06.007","volume":"69","author":"RD White","year":"2014","unstructured":"White RD, Weir-McCall JR, Budak MJ, Waugh SA, Munnoch DA, Sudarshan TAP (2014) Contrast-enhanced magnetic resonance lymphography in the assessment of lower limb lymphoedema. Clin Radiol 69:E435\u2013E444","journal-title":"Clin Radiol"},{"key":"1918_CR4","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1002\/jmri.24887","volume":"42","author":"LM Mitsumori","year":"2015","unstructured":"Mitsumori LM, McDonald ES, Wilson GJ, Neligan PC, Minoshima S, Maki JH (2015) MR lymphangiography: how i do it. J Magn Reson Imaging 42:1465\u20131477","journal-title":"J Magn Reson Imaging"},{"key":"1918_CR5","doi-asserted-by":"publisher","first-page":"e3109","DOI":"10.1097\/MD.0000000000003109","volume":"95","author":"EY Kim","year":"2016","unstructured":"Kim EY, Hwang HS, Lee HY et al (2016) Anatomic and functional evaluation of central lymphatics with noninvasive magnetic resonance lymphangiography. Medicine 95:e3109","journal-title":"Medicine"},{"key":"1918_CR6","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1002\/jmri.28496","volume":"57","author":"BP Salehi","year":"2023","unstructured":"Salehi BP, Sibley RC, Friedman R et al (2023) MRI of lymphedema. J Magn Reson Imaging 57:977\u2013991","journal-title":"J Magn Reson Imaging"},{"key":"1918_CR7","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.ejso.2013.11.027","volume":"40","author":"L Xiong","year":"2014","unstructured":"Xiong L, Engel H, Gazyakan E et al (2014) Current techniques for lymphatic imaging: State of the art and future perspectives. Ejso-Eur J Surg Onc 40:270\u2013276","journal-title":"Ejso-Eur J Surg Onc"},{"key":"1918_CR8","doi-asserted-by":"publisher","first-page":"587","DOI":"10.5152\/dir.2020.19482","volume":"26","author":"S Guerrini","year":"2020","unstructured":"Guerrini S, Gentili F, Mazzei FG, Gennaro P, Volterrani L, Mazzei MA (2020) Magnetic resonance lymphangiography: with or without contrast? Diagn Interv Radiol 26:587\u2013595","journal-title":"Diagn Interv Radiol"},{"key":"1918_CR9","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1002\/jmri.27542","volume":"53","author":"M Mills","year":"2021","unstructured":"Mills M, van Zanten M, Borri M et al (2021) Systematic review of magnetic resonance lymphangiography from a technical perspective. J Magn Reson Imaging 53:1766\u20131790","journal-title":"J Magn Reson Imaging"},{"key":"1918_CR10","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1148\/radiol.2203010090","volume":"220","author":"SG Ruehm","year":"2001","unstructured":"Ruehm SG, Schroeder T, Debatin JF (2001) Interstitial MR lymphography with gadoterate meglumine: Initial experience in humans. Radiology 220:816\u2013821","journal-title":"Radiology"},{"key":"1918_CR11","doi-asserted-by":"publisher","first-page":"556","DOI":"10.2214\/AJR.05.1750","volume":"187","author":"C Lohrmann","year":"2006","unstructured":"Lohrmann C, Foeldi E, Speck O, Langer M (2006) High-resolution MR lymphangiography in patients with primary and secondary lymphedema. AJR Am J Roentgenol 187:556\u2013561","journal-title":"AJR Am J Roentgenol"},{"key":"1918_CR12","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.ejrad.2006.02.012","volume":"59","author":"C Lohrmann","year":"2006","unstructured":"Lohrmann C, Foeldi E, Langer M (2006) Indirect magnetic resonance lymphangiography in patients with lymphedema preliminary results in humans. Eur J Radiol 59:401\u2013406","journal-title":"Eur J Radiol"},{"key":"1918_CR13","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1002\/micr.20968","volume":"32","author":"G Felmerer","year":"2012","unstructured":"Felmerer G, Sattler T, Lohrmann C, Tobbia D (2012) Treatment of various secondary lymphedemas by microsurgical lymph vessel transplantation. Microsurg 32:171\u2013177","journal-title":"Microsurg"},{"key":"1918_CR14","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1053\/j.tvir.2016.10.007","volume":"19","author":"LM Mitsumori","year":"2016","unstructured":"Mitsumori LM, McDonald ES, Neligan PC, Maki JH (2016) Peripheral magnetic resonance lymphangiography: techniques and applications. Tech Vasc Interv Radiol 19:262\u2013272","journal-title":"Tech Vasc Interv Radiol"},{"key":"1918_CR15","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1002\/jmri.25313","volume":"44","author":"LM Mitsumori","year":"2016","unstructured":"Mitsumori LM (2016) Response: Magnetic resonance lymphangiography: How to prove it? J Magn Reson Imaging 44:1368\u20131369","journal-title":"J Magn Reson Imaging"},{"key":"1918_CR16","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1067\/j.cpradiol.2015.08.003","volume":"45","author":"JH Maki","year":"2016","unstructured":"Maki JH, Neligan PC, Briller N, Mitsumori LM, Wilson GJ (2016) Dark blood magnetic resonance lymphangiography using dual-agent relaxivity contrast (DARC-MRL): a novel method combining gadolinium and iron contrast agents. Curr Probl Diagn Radiol 45:174\u2013179","journal-title":"Curr Probl Diagn Radiol"},{"key":"1918_CR17","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.jconrel.2005.12.019","volume":"111","author":"H Kobayashi","year":"2006","unstructured":"Kobayashi H, Kawamoto S, Bernardo M, Brechbiel MW, Knopp MV, Choyke PL (2006) Delivery of gadolinium-labeled nanoparticles to the sentinel lymph node: Comparison of the sentinel node visualization and estimations of intra-nodal gadolinium concentration by the magnetic resonance imaging. J Control Release 111:343\u2013351","journal-title":"J Control Release"},{"key":"1918_CR18","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1002\/mrm.10583","volume":"50","author":"H Kobayashi","year":"2003","unstructured":"Kobayashi H, Kawamoto S, Choyke PL et al (2003) Comparison of dendrimer-based macromolecular contrast agents for dynamic micro-magnetic resonance lymphangiography. Magn Reson Med 50:758\u2013766","journal-title":"Magn Reson Med"},{"key":"1918_CR19","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1097\/RLI.0000000000000398","volume":"52","author":"A M\u00fcller","year":"2017","unstructured":"M\u00fcller A, Fries P, Jelvani B et al (2017) Magnetic Resonance lymphography at 9.4 T using a gadolinium-based nanoparticle in rats. Invest Radiol 52:725\u2013733","journal-title":"Invest Radiol"},{"key":"1918_CR20","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1148\/radiol.2423061640","volume":"242","author":"PH Kuo","year":"2007","unstructured":"Kuo PH, Kanal E, Abu-Alfa AK, Cowper SE (2007) Gadolinium-based MR contrast agents and nephrogenic systemic fibrosis. Radiology 242:647\u2013649","journal-title":"Radiology"},{"key":"1918_CR21","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1148\/radiol.2020202903","volume":"298","author":"JC Weinreb","year":"2021","unstructured":"Weinreb JC, Rodby RA, Yee J et al (2021) Use of intravenous gadolinium-based contrast media in patients with kidney disease: consensus statements from the American College of Radiology and the National Kidney Foundation. Radiology 298:28\u201335","journal-title":"Radiology"},{"key":"1918_CR22","doi-asserted-by":"crossref","unstructured":"Cheong BYC, Wilson JM, Preventza OA, Muthupillai R (2022) Gadolinium-based contrast agents: updates and answers to typical questions regarding gadolinium use. Tex Heart I J 49(3):e217680","DOI":"10.14503\/THIJ-21-7680"},{"key":"1918_CR23","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/s41551-021-00687-z","volume":"5","author":"TH Shin","year":"2021","unstructured":"Shin TH, Kim PK, Kang S et al (2021) High-resolution T(1) MRI via renally clearable dextran nanoparticles with an iron oxide shell. Nat Biomed Eng 5:252\u2013263","journal-title":"Nat Biomed Eng"},{"key":"1918_CR24","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1089\/lrb.2007.5302","volume":"5","author":"R Mounzer","year":"2007","unstructured":"Mounzer R, Shkarin P, Papademetris X, Constable T, Ruddle NH, Fahmy TM (2007) Dynamic imaging of lymphatic vessels and lymph nodes using a bimodal nanoparticulate contrast agent. Lymphat Res Biol 5:151\u2013158","journal-title":"Lymphat Res Biol"},{"key":"1918_CR25","doi-asserted-by":"publisher","first-page":"3159","DOI":"10.3390\/molecules25143159","volume":"25","author":"N Malhotra","year":"2020","unstructured":"Malhotra N, Lee JS, Liman RAD et al (2020) Potential toxicity of iron oxide magnetic nanoparticles: a review. Molecules 25:3159","journal-title":"Molecules"},{"key":"1918_CR26","doi-asserted-by":"publisher","first-page":"105","DOI":"10.2214\/AJR.19.21264","volume":"214","author":"B Turkbey","year":"2020","unstructured":"Turkbey B, Czarniecki M, Shih JH et al (2020) Ferumoxytol-enhanced MR lymphography for detection of metastatic lymph nodes in genitourinary malignancies: a prospective study. AJR Am J Roentgenol 214:105\u2013113","journal-title":"AJR Am J Roentgenol"},{"key":"1918_CR27","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.2214\/AJR.19.22187","volume":"215","author":"BE Hamilton","year":"2020","unstructured":"Hamilton BE (2020) Ferumoxytol-enhanced MRI is not inferior to gadolinium-enhanced MRI in detecting intracranial metastatic disease and metastasis size. Am J Roentgenol 215:1551\u20131551","journal-title":"Am J Roentgenol"},{"key":"1918_CR28","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1007\/s00247-021-05098-5","volume":"52","author":"HE Daldrup-Link","year":"2022","unstructured":"Daldrup-Link HE, Theruvath AJ, Rashidi A et al (2022) How to stop using gadolinium chelates for magnetic resonance imaging: clinical-translational experiences with ferumoxytol. Pediatr Radiol 52:354\u2013366","journal-title":"Pediatr Radiol"},{"key":"1918_CR29","doi-asserted-by":"crossref","unstructured":"Werner P, Taupitz M, Schr\u00f6der L, Schuenke P (2021) An NMR relaxometry approach for quantitative investigation of the transchelation of gadolinium ions from GBCAs to a competing macromolecular chelator. Sci Rep-Uk 11","DOI":"10.1038\/s41598-021-00974-4"}],"container-title":["Molecular Imaging and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-024-01918-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11307-024-01918-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-024-01918-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T05:39:00Z","timestamp":1725255540000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11307-024-01918-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,29]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["1918"],"URL":"https:\/\/doi.org\/10.1007\/s11307-024-01918-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3807460\/v1","asserted-by":"object"}]},"ISSN":["1536-1632","1860-2002"],"issn-type":[{"value":"1536-1632","type":"print"},{"value":"1860-2002","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,29]]},"assertion":[{"value":"28 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"K.W.K. & M.H.K. are employed by Trial Informatics. J.W.K. & T.H.S.\u00a0are employed by Inventera Inc., a startup focused on developing nanoimaging agents. There are no other financial interests or potential conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure of Conflicts of Interest"}}]}}